CO2018006393A2 - Método para fabricar un dispositivo para la administración de fármacos y un dispositivo para la administración de fármacos fabricado según el método - Google Patents

Método para fabricar un dispositivo para la administración de fármacos y un dispositivo para la administración de fármacos fabricado según el método

Info

Publication number
CO2018006393A2
CO2018006393A2 CONC2018/0006393A CO2018006393A CO2018006393A2 CO 2018006393 A2 CO2018006393 A2 CO 2018006393A2 CO 2018006393 A CO2018006393 A CO 2018006393A CO 2018006393 A2 CO2018006393 A2 CO 2018006393A2
Authority
CO
Colombia
Prior art keywords
delivery device
drug delivery
manufactured according
manufacturing
device manufactured
Prior art date
Application number
CONC2018/0006393A
Other languages
English (en)
Inventor
Svante Holmberg
Heikki Lyytikäinen
Christine Talling
Saara Ruotsalainen
Petri Laakso
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of CO2018006393A2 publication Critical patent/CO2018006393A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1475—Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Lining Or Joining Of Plastics Or The Like (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

La invención se refiere a un método para producir un dispositivo para la administración de fármacos, el cual tiene un cuerpo que comprende un elastómero a base de siloxano y por lo menos un agente activo. El método comprende la aplicación de material adhesivo, el cual comprende elastómero a base de siloxano sin curar, en contacto con el cuerpo y curado de dicho material adhesivo sometiéndolo a energía de radiación desde una fuente láser. La invención se refiere además a un dispositivo para la administración de fármacos manufacturado de acuerdo con el método.
CONC2018/0006393A 2015-12-21 2018-06-21 Método para fabricar un dispositivo para la administración de fármacos y un dispositivo para la administración de fármacos fabricado según el método CO2018006393A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15201533 2015-12-21
PCT/EP2016/081715 WO2017108676A1 (en) 2015-12-21 2016-12-19 Method for manufacturing a drug delivery device and a drug delivery device manufactured according to the method

Publications (1)

Publication Number Publication Date
CO2018006393A2 true CO2018006393A2 (es) 2018-07-10

Family

ID=55024876

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0006393A CO2018006393A2 (es) 2015-12-21 2018-06-21 Método para fabricar un dispositivo para la administración de fármacos y un dispositivo para la administración de fármacos fabricado según el método

Country Status (23)

Country Link
US (1) US11007140B2 (es)
EP (1) EP3393452B1 (es)
JP (1) JP6936801B2 (es)
KR (1) KR20180103071A (es)
CN (1) CN108430453B (es)
AR (1) AR107098A1 (es)
AU (1) AU2016375432A1 (es)
BR (1) BR112018012743A2 (es)
CA (1) CA3008941C (es)
CL (1) CL2018001691A1 (es)
CO (1) CO2018006393A2 (es)
HK (1) HK1257934A1 (es)
IL (1) IL259343A (es)
JO (1) JOP20160267B1 (es)
MX (1) MX2018007675A (es)
MY (1) MY193641A (es)
PE (1) PE20181214A1 (es)
RU (1) RU2732822C2 (es)
SG (1) SG11201805114RA (es)
TW (1) TWI726956B (es)
UA (1) UA124382C2 (es)
UY (1) UY37043A (es)
WO (1) WO2017108676A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019063382A1 (en) * 2017-09-27 2019-04-04 Bayer Oy METHOD FOR MODIFYING THE RELEASE OF A THERAPEUTICALLY ACTIVE AGENT FROM AN ELASTOMERIC MATRIX

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US6846852B2 (en) * 2001-08-16 2005-01-25 Goldschmidt Ag Siloxane-containing compositions curable by radiation to silicone elastomers
CN1403172A (zh) * 2001-09-07 2003-03-19 上海市计划生育科学研究所 一种用于治疗妇女更年期综合症的药物控释装置
CN1264488C (zh) * 2003-05-14 2006-07-19 上海市计划生育科学研究所 阴道环简易制备方法
NZ571758A (en) * 2006-03-31 2012-06-29 Quadra Logic Tech Inc A drug insert surrounded by a sheath to expose a polymer containing a drug to surrounding tissues or an eye
US20070260300A1 (en) * 2006-05-04 2007-11-08 Daniel Gregorich Intraluminal medical device having a curable coating
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) * 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
WO2010056543A1 (en) * 2008-10-29 2010-05-20 3M Innovative Properties Company Electron beam cured, nonfunctionalized silicone pressure sensitive adhesives
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
US8212934B2 (en) * 2009-02-19 2012-07-03 Sony Corporation Method for processing an analog television signal
FI20095563A (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
AU2010274946B2 (en) * 2009-07-21 2013-09-12 The Population Council, Inc. Multi-layered gradient vaginal ring
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
WO2012024461A2 (en) * 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
US20120057219A1 (en) * 2010-09-07 2012-03-08 Panasonic Corporation Laser light source apparatus
CN105853445A (zh) * 2011-06-06 2016-08-17 橡冠科学研究院 采用芯吸释放窗口的药物递送装置
EP2850145A4 (en) * 2012-05-18 2016-02-10 3M Innovative Properties Co ADHESIVE PRODUCTS FOR MEDICAL APPLICATIONS
WO2014093093A1 (en) * 2012-12-12 2014-06-19 3M Innovative Properties Company Room temperature curable siloxane-based gels
JP6657897B2 (ja) * 2015-12-10 2020-03-04 株式会社リコー ミラー部材の加工方法

Also Published As

Publication number Publication date
HK1257934A1 (zh) 2019-11-01
JP6936801B2 (ja) 2021-09-22
AR107098A1 (es) 2018-03-21
JP2019502702A (ja) 2019-01-31
UA124382C2 (uk) 2021-09-08
BR112018012743A2 (pt) 2018-12-04
WO2017108676A1 (en) 2017-06-29
MY193641A (en) 2022-10-21
US20190000751A1 (en) 2019-01-03
RU2732822C2 (ru) 2020-09-22
AU2016375432A1 (en) 2018-06-14
US11007140B2 (en) 2021-05-18
CL2018001691A1 (es) 2018-10-05
PE20181214A1 (es) 2018-07-24
SG11201805114RA (en) 2018-07-30
CA3008941C (en) 2024-01-02
EP3393452B1 (en) 2021-08-04
TW201726069A (zh) 2017-08-01
RU2018126720A3 (es) 2020-04-06
CA3008941A1 (en) 2017-06-29
RU2018126720A (ru) 2020-01-24
IL259343A (en) 2018-07-31
CN108430453A (zh) 2018-08-21
MX2018007675A (es) 2018-09-12
UY37043A (es) 2017-07-31
KR20180103071A (ko) 2018-09-18
EP3393452A1 (en) 2018-10-31
TWI726956B (zh) 2021-05-11
JOP20160267B1 (ar) 2021-08-17
CN108430453B (zh) 2023-03-17

Similar Documents

Publication Publication Date Title
NI201800038S (es) Dispositivo de administración de medicamento intranasal
CO2019009680A2 (es) Anticuerpo anti-gprc5d y molécula que comprende el anticuerpo
CY1124380T1 (el) Συστηματα διαβλεννογονιας και διαδερμικης χορηγησης
BR112018003985A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
CL2016002372A1 (es) Cenicriviroc para el tratamiento de la fibrosis.
CU20160164A7 (es) Un nanocomplejo micelar
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
CL2019000493A1 (es) Sistema y método para terapia médica controlada.
CY1122716T1 (el) Ρινικη συσταση κονεως για την αγωγη της υπογλυκαιμιας
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
BR112018075027A2 (pt) métodos de fabricação de aplicadores de precisão
CL2016001160A1 (es) Dispositivo intraocular de suministro de fármacos de liberación sostenida configurado para el surco de los ojos, que comprende un núcleo de matriz polimérica con agente terapéutico y un revestimiento polimérico que rodea a la matriz y el dispositivo se forma de un segmento anular con un diámetro de sección transversal que varía de 0,10-0,80 mm.
NI201500150A (es) TRATAMIENTO DE CÁNCER CON DIHIDROPIRAZINO-PIRAZINAS×Se proporcionan en la presente método
AR095003A1 (es) Un agente de sostén
AR105205A1 (es) Sustrato adhesivo desechable adaptado para ser dispuesto sobre un dispositivo médico
AR097210A1 (es) Composición para la aglomeración de finos
MX2017000141A (es) Nanoparticulas terapeuticas dirigidas y metodos para elaborar y utilizar las mismas.
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
BR112018006870A2 (pt) nanopartículas terapêuticas que compreendem um agente terapêutico e métodos para a produção e o uso das mesmas
CL2018001691A1 (es) Método para fabricar un dispositivo para la administración de fármacos y un dispositivo para la administración de fármacos fabricado según el método
CL2015003554A1 (es) Preparado farmacéutico.
CL2015002560A1 (es) Un método para tratar infecciones, enfermedades o desordenes de la unidad ungueal, con un dispositivo para implantar una composición en una ubicación determinada y un régimen de dosificación para tratar una enfermedad o trastorno de la unidad ungueal.
MX2020003665A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.
CO2018001251A2 (es) Material no tejido tratado que tiene una afinidad por un ingrediente activo y método de fabricación del mismo
BR112017002915A2 (pt) processo para manufaturar um dispositivo de uso médico customizável e dispositivo obtido pelo dito processo